Group 1 - The company held an investor meeting on January 4, 2026, to discuss business progress, performance planning, and technology layout with institutional investors [1] - Key participants included the company's Vice General Manager and Board Secretary, Investment Director, and heads of various departments [1] Group 2 - The joint venture company is focused on developing next-generation edge brain-machine interface algorithm chips and advancing mixed biometric and brain signal analysis [2] - The joint venture is currently in the process of business registration [2] Group 3 - The company has set its 2026 performance targets based on the 2025 restricted stock incentive plan and employee stock ownership plan [3] - To achieve these targets, the company plans to leverage AI technology, enhance brand influence, and expand market space [3] Group 4 - The performance assessment for the stock incentive plan excludes results from acquisitions, focusing instead on the company's organic growth capabilities [4] Group 5 - The company's non-invasive brain-machine business leverages long-term AI cognitive computing expertise, focusing on BioCV TinyML edge model development [5] - This approach aims to optimize brain-machine interaction across various elements by integrating perception, analysis, and decision-making capabilities into edge devices [5] Group 6 - The partnership with ShenNian Technology is based on its 20 years of industry experience, strong data accumulation, and a cross-disciplinary team [6] - ShenNian's business model, which combines chips and algorithm SDKs, has been successfully validated [6] Group 7 - The company has not yet adopted digital RMB for cross-border settlements and is managing exchange rate risks through global supply chain strategies and local operations [7] - The company employs various methods to hedge against currency risks, including forward foreign exchange contracts and attempts at cross-border RMB settlements [7]

Core Viewpoint - The company, Entropy Technology, reported a steady increase in profitability for 2024, achieving a revenue of 1.99 billion yuan and a net profit of 183 million yuan, amidst a complex global economic environment [1] Group 1: Financial Performance - In 2024, the company achieved an operating income of 1.99 billion yuan, representing a year-on-year increase of 1.07% [1] - The net profit attributable to the parent company was 183 million yuan, reflecting a year-on-year growth of 3.26% [1] Group 2: Business Focus and Innovation - The company is dedicated to advancing its core technology in multi-modal BioCV (computer vision and biometrics) and AI cognitive spatial computing, focusing on four main business areas: smart space, smart office, digital identity authentication, and smart commerce [1] - The company invested over 215 million yuan in R&D for 2024, with R&D expenditures exceeding 10% of operating income for the past two years [2] - During the reporting period, the company added 105 new patents and participated in the formulation of 32 national and local industry standards, enhancing its competitive edge [2] Group 3: Product Development - The company launched its next-generation AI cognitive spatial platform, Mars Wisdom, in February 2025, which utilizes its proprietary BioCV multi-modal model to redefine smart space boundaries [3] - The Mars Wisdom platform collaborates with the company's flagship product, Wan Ao Rui Da, to provide comprehensive support from data collection to intelligent decision-making [3] Group 4: Market Expansion - Since its establishment in 2007, the company has maintained a global innovation-driven strategy, covering over 100 countries and regions [4] - In 2024, the company's overseas sales revenue reached 1.41 billion yuan, accounting for 71.17% of its main business income [4] - The company plans to deepen the integration of multi-modal technology with AI large models and aims to become a global leader in smart space evolution services by 2025 [4]